The funding will support the Good Bugs, Bad Bugs program as well as the Canadian Research Data Centre Network.
The discovery of a combination therapy has the potential to change medical practice for the treatment of the drug resistant infections which the World Health Organization has identified as of “critical priority” for their threat to human health.